SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/08/19 Biolase, Inc 10-K 12/31/18 86:14M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.28M 2: EX-10.28 Material Contract HTML 93K 3: EX-21.1 Subsidiaries List HTML 22K 4: EX-23.1 Consent of Experts or Counsel HTML 26K 5: EX-31.1 Certification -- §302 - SOA'02 HTML 32K 6: EX-31.2 Certification -- §302 - SOA'02 HTML 32K 7: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 8: EX-32.2 Certification -- §906 - SOA'02 HTML 26K 15: R1 Document and Entity Information HTML 60K 16: R2 Consolidated Balance Sheets HTML 109K 17: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K 18: R4 Consolidated Statements Of Operations And HTML 108K Comprehensive Loss 19: R5 Consolidated Statements Of Shareholders' Equity HTML 95K 20: R6 Consolidated Statements Of Shareholders' Equity HTML 26K (Parenthetical) 21: R7 Consolidated Statements Of Cash Flows HTML 141K 22: R8 Basis of Presentation HTML 43K 23: R9 Summary of Significant Accounting Policies HTML 277K 24: R10 Supplementary Balance Sheet Information HTML 138K 25: R11 Intangible Assets and Goodwill HTML 66K 26: R12 Income Taxes HTML 226K 27: R13 Debt HTML 91K 28: R14 Commitments and Contingencies HTML 47K 29: R15 Stockholders' Equity HTML 418K 30: R16 Segment Information HTML 49K 31: R17 Concentrations HTML 89K 32: R18 Subsequent Events (Unaudited) HTML 31K 33: R19 Schedule II-Consolidated Valuation and Qualifying HTML 118K Accounts and Reserves 34: R20 Summary of Significant Accounting Policies HTML 367K (Policies) 35: R21 Summary of Significant Accounting Policies HTML 242K (Tables) 36: R22 Supplementary Balance Sheet Information (Tables) HTML 144K 37: R23 Intangible Assets and Goodwill (Tables) HTML 64K 38: R24 Income Taxes (Tables) HTML 224K 39: R25 Debt (Tables) HTML 78K 40: R26 Commitments and Contingencies (Tables) HTML 36K 41: R27 Stockholders' Equity (Tables) HTML 353K 42: R28 Segment Information (Tables) HTML 47K 43: R29 Concentrations (Tables) HTML 89K 44: R30 Basis of Presentation - Additional Information HTML 68K (Detail) 45: R31 Summary of Significant Accounting Policies - HTML 100K Additional Information (Detail) 46: R32 Schedule of Reconciliation of Cash, Cash HTML 36K Equivalents, and Restricted Cash (Detail) 47: R33 Estimated Useful Lives of Property, Plant and HTML 38K Equipment (Detail) 48: R34 Summary of Opening and Closing Balances of HTML 40K Contract Liabilities (Detail) 49: R35 Summary of Disaggregation of Revenues Related to HTML 32K Geographic Areas (Detail) 50: R36 Summary of Revenues Disaggregated by Timing of HTML 33K Goods and Services Transferred (Detail) 51: R37 Summary of Sales by End Market (Detail) HTML 33K 52: R38 Changes in Initial Product Warranty Accrual and HTML 40K Expenses Under Initial and Extended Warranties (Detail) 53: R39 Classification of Compensation Expense Associated HTML 38K with Share-Based Payments (Detail) 54: R40 Assumptions Used in Estimating Fair Value of Stock HTML 33K Options Granted (Detail) 55: R41 Components of Accounts Receivable, Net of HTML 33K Allowance (Detail) 56: R42 Supplementary Balance Sheet Information - HTML 42K Additional Information (Detail) 57: R43 Components of Inventory (Detail) HTML 35K 58: R44 Summary of Property, Plant, and Equipment (Detail) HTML 50K 59: R45 Components of Accrued Liabilities (Detail) HTML 49K 60: R46 Intangible Assets and Goodwill - Additional HTML 33K Information (Detail) 61: R47 Intangible Assets and Related Accumulated HTML 52K Amortization (Detail) 62: R48 Summary of Income Tax Current and Deferred HTML 43K Provision (Detail) 63: R49 Federal Income Tax Provision Compared With HTML 55K Statutory Rates (Detail) 64: R50 Summary of Net Deferred Tax Assets and Net HTML 78K Deferred Tax Liabilities (Detail) 65: R51 Income Taxes - Additional Information (Detail) HTML 80K 66: R52 Summary of Unrecognized Tax Benefits (Detail) HTML 31K 67: R53 Debt - Summary of Principal Outstanding and HTML 32K Unamortized Discount (Detail) 68: R54 Debt - Additional Information (Detail) HTML 161K 69: R55 Debt - Summary of Future Minimum Principal HTML 51K Payments (Detail) 70: R56 Commitments and Contingencies - Additional HTML 48K Information (Detail) 71: R57 Future Minimum Rental Commitments Under Lease HTML 35K Agreements (Detail) 72: R58 Stockholders' Equity - Additional Information HTML 810K (Detail) 73: R59 Summary of Warrant Activity (Detail) HTML 54K 74: R60 Summary of Option Activity (Detail) HTML 66K 75: R61 Options Outstanding and Exercisable (Detail) HTML 66K 76: R62 Cash Proceeds Along with Fair Value Disclosures HTML 36K Related to Grants, Exercises, and Vesting Options (Detail) 77: R63 Summary of Unvested Restricted Stock Units HTML 37K (Detail) 78: R64 Segment Information - Additional Information HTML 38K (Detail) 79: R65 Summary of Long-Lived Assets by Geographic HTML 33K Location (Detail) 80: R66 Concentrations - Summary of Net Revenue from HTML 52K Various Products (Detail) 81: R67 Concentrations - Additional Information (Detail) HTML 33K 82: R68 Subsequent Events (unaudited) - Additional HTML 63K Information (Detail) 83: R69 Consolidated Valuation and Qualifying Accounts and HTML 39K Reserves (Detail) 85: XML IDEA XML File -- Filing Summary XML 152K 84: EXCEL IDEA Workbook of Financial Reports XLSX 114K 9: EX-101.INS XBRL Instance -- biol-20181231 XML 4.07M 11: EX-101.CAL XBRL Calculations -- biol-20181231_cal XML 226K 12: EX-101.DEF XBRL Definitions -- biol-20181231_def XML 707K 13: EX-101.LAB XBRL Labels -- biol-20181231_lab XML 1.72M 14: EX-101.PRE XBRL Presentations -- biol-20181231_pre XML 1.23M 10: EX-101.SCH XBRL Schema -- biol-20181231 XSD 257K 86: ZIP XBRL Zipped Folder -- 0001564590-19-006918-xbrl Zip 248K
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
BIOLASE, Inc.
Irvine, California
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-194889, 333-144095, 333-112173, 333-130677, 333-177339, 333-204059, and 333-150105) and Form S-3 (Nos. 333-222564, 333-219406, 333-106260, 333-200623, 333-198291, 333-166145, 333-190158, 333-193426, 333-214281, 333-175664, 333-141417, 333-106290, 333-89692, and 333-58329) of BIOLASE, Inc. of our report dated March 8, 2019, relating to the consolidated financial statements and consolidated financial statement schedule of BIOLASE, Inc., which appear in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
Costa Mesa, California
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/8/19 | |||
For Period end: | 12/31/18 | SD | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/29/22 Biolase, Inc. 424B5 1:399K Donnelley … Solutions/FA 3/31/21 Biolase, Inc. 10-K 12/31/20 88:15M ActiveDisclosure/FA 2/09/21 Biolase, Inc. 424B5 1:495K Donnelley … Solutions/FA 12/08/20 Biolase, Inc. S-1/A 3:585K Donnelley … Solutions/FA |